Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II or Stage III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer - NCT00951496-54601(Clinical Trial 330407)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
La Crosse |
|
State:
|
|
WI |
| Zip Code: |
|
54601 |
| Conditions: |
|
Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer |
| Purpose: |
|
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different
ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and
help kill them or carry tumor-killing substances to them. Drugs used in chemotherapy, such
as paclitaxel, carboplatin, and cisplatin, work in different ways to stop the growth of
tumor cells, either by killing the cells or by stopping them from dividing. It is not yet
known whether giving bevacizumab together with intravenous chemotherapy is more effective
than giving bevacizumab together with intraperitoneal chemotherapy in treating patients with
ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer.
PURPOSE: This randomized phase III trial is studying bevacizumab and intravenous
chemotherapy to see how well they work compared with bevacizumab and intraperitoneal
chemotherapy in treating patients with stage II or stage III ovarian epithelial cancer,
fallopian tube cancer, or primary peritoneal cancer.
|
| Study summary: |
|
This study is no longer available. |
| Criteria: |
|
This study is no longer available. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
December 30, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|